EGFR and PDL1: A Match (Not) Made in Heaven-A Real-World Retrospective Analysis of PDL1 Expression in EGFR-Mutated NSCLC.
Ullas BatraMansi SharmaShrinidhi NathanyAbhishek BansalSunil PasrichaParveen JainAnurag MehtaHarkirat SinghPublished in: Advances in therapy (2021)
The current study was an exploratory retrospective study; however, the results add to the growing body of evidence that PDL1 expression in EGFR-mutated NSCLC does not have any prognostic significance. Also the efficacy of EGFR TKIs is not influenced by variations in PDL1 TPS.